• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤初次诊断和治疗后随访期间不同类型癌症的发病率。对709名患者群体进行的单中心4年随访。

Incidence of different types of cancer in the follow-up period after primary diagnosis and treatment of melanoma. Single-centre 4-year follow-up on a population of 709 patients.

作者信息

Ziętek Marcin, Wierzbicki Jędrzej, Nowacki Maciej, Czajkowski Rafał, Wroński Piotr, Nowacka Katarzyna, Pawlak Edyta, Maciejczyk Adam, Matkowski Rafał

机构信息

Lower Silesian Oncology, Pulmonology and Haematology Centre, Wroclaw, Poland.

Department of Oncology, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Postepy Dermatol Alergol. 2023 Jun;40(3):416-420. doi: 10.5114/ada.2023.127545. Epub 2023 Jun 21.

DOI:10.5114/ada.2023.127545
PMID:37545825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10399667/
Abstract

INTRODUCTION

Follow-up plays a key role in melanoma management, especially in the first years after diagnosis. During this period it is crucial to assess possible recurrence, progression of the disease or treatment complications. An important aspect is also the possibility of formation of new primary foci or other skin cancers.

AIM

To assess the coincidence of skin lesions and cancers among the melanoma patients.

MATERIAL AND METHODS

Patients treated in the Comprehensive Cancer Centre between 2019 and 2022 were retrospectively analysed for occurrence of skin lesions diagnosed during the follow-up, and confirmed by biopsy. The lesions considered included skin cancers, dysplastic nevus and actinic keratosis.

RESULTS

In 100 (14%) out of 709 enrolled patients, 184 lesions were diagnosed. In 7 patients it was melanoma, in 49 BCC, and in 16 SCC. Dysplastic nevus and actinic keratosis were excised in 28 and 14 patients, respectively. More than one site of the skin lesion was observed in 39 patients, and more than one type of the lesion in 13 patients. Patients with lesions were on average 8.6 years older ( < 0.001), had less advanced tumours ( = 0.010), and primary melanoma was more often located on the head and neck ( = 0.056).

CONCLUSIONS

Among melanoma patients, particular attention must be paid to, apart from early detection of melanoma recurrence and progression, the occurrence of new primary foci or independent skin cancers.

摘要

引言

随访在黑色素瘤管理中起着关键作用,尤其是在诊断后的头几年。在此期间,评估疾病的可能复发、进展或治疗并发症至关重要。一个重要方面还包括形成新的原发性病灶或其他皮肤癌的可能性。

目的

评估黑色素瘤患者中皮肤病变与癌症的巧合情况。

材料与方法

对2019年至2022年在综合癌症中心接受治疗的患者进行回顾性分析,以确定随访期间诊断出并经活检证实的皮肤病变的发生情况。所考虑的病变包括皮肤癌、发育异常痣和光化性角化病。

结果

在709名登记患者中的100名(14%)中,诊断出184处病变。其中7例为黑色素瘤,49例为基底细胞癌,16例为鳞状细胞癌。分别有28例和14例患者切除了发育异常痣和光化性角化病。39例患者观察到不止一处皮肤病变,13例患者观察到不止一种类型的病变。有病变的患者平均年龄大8.6岁(<0.001),肿瘤分期较低(=0.010),原发性黑色素瘤更常位于头颈部(=0.056)。

结论

在黑色素瘤患者中,除了早期发现黑色素瘤复发和进展外,还必须特别关注新的原发性病灶或独立皮肤癌的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba31/10399667/66ba5fabd8d5/PDIA-40-50700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba31/10399667/66ba5fabd8d5/PDIA-40-50700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba31/10399667/66ba5fabd8d5/PDIA-40-50700-g001.jpg

相似文献

1
Incidence of different types of cancer in the follow-up period after primary diagnosis and treatment of melanoma. Single-centre 4-year follow-up on a population of 709 patients.黑色素瘤初次诊断和治疗后随访期间不同类型癌症的发病率。对709名患者群体进行的单中心4年随访。
Postepy Dermatol Alergol. 2023 Jun;40(3):416-420. doi: 10.5114/ada.2023.127545. Epub 2023 Jun 21.
2
Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?COVID-19 大流行期间肾移植受者中非黑色素瘤皮肤癌的诊断延迟:口罩背后隐藏着什么?
Acta Dermatovenerol Croat. 2021 Jul;29(2):111-113.
3
Meyerson Phenomenon as a Component of Melanoma in situ.迈耶森现象作为原位黑色素瘤的一个组成部分。
Acta Dermatovenerol Croat. 2016 Apr;24(1):81-2.
4
The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.转移性黑色素瘤患者中非黑色素瘤恶性皮肤病变和非皮肤鳞状细胞癌的发生情况:丹麦的一项观察性队列研究
BMC Cancer. 2016 May 3;16:295. doi: 10.1186/s12885-016-2315-0.
5
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.体内反射共聚焦显微镜在黑素细胞性病变分析中的作用
Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67.
6
Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.用于诊断成人基底细胞癌和其他皮肤癌的脱落细胞学检查。
Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD013187. doi: 10.1002/14651858.CD013187.
7
Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.皮肤鳞状细胞癌患者的癌前病变、基底细胞癌和黑色素瘤。
Arch Dermatol Res. 2021 Dec;313(10):879-884. doi: 10.1007/s00403-020-02114-w. Epub 2020 Aug 9.
8
9
Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.荷兰基于人群队列中首次黑色素瘤、鳞状细胞癌和基底细胞癌后不同皮肤肿瘤组合的风险:1989-2009 年。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):382-389. doi: 10.1111/jdv.14587. Epub 2017 Oct 17.
10
Precursors to skin cancer.皮肤癌的前驱病变
Cancer. 1995 Jan 15;75(2 Suppl):645-50. doi: 10.1002/1097-0142(19950115)75:2+<645::aid-cncr2820751405>3.0.co;2-1.

本文引用的文献

1
Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies.根据新疗法来看,伴有淋巴结转移的IIIC期和IIID期黑色素瘤患者的生存率。
Postepy Dermatol Alergol. 2022 Dec;39(6):1141-1150. doi: 10.5114/ada.2022.119971. Epub 2022 Oct 3.
2
Novel therapies for advanced skin carcinomas.晚期皮肤癌的新型疗法。
Postepy Dermatol Alergol. 2020 Oct;37(5):660-670. doi: 10.5114/ada.2020.100479. Epub 2020 Nov 7.
3
The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
反射式共聚焦显微镜在鉴别原位黑色素瘤与伴有重度异型的发育不良痣中的作用:一项横断面研究。
J Am Acad Dermatol. 2020 Oct;83(4):1035-1043. doi: 10.1016/j.jaad.2020.05.071. Epub 2020 May 19.
4
Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.成年癌症幸存者完成原发性癌症治疗后的随访策略。
Cochrane Database Syst Rev. 2019 Nov 21;2019(11):CD012425. doi: 10.1002/14651858.CD012425.pub2.
5
"Lost to Follow-up" Among Adult Cancer Survivors.成年癌症幸存者中的“失访”情况
Am J Clin Oncol. 2018 Oct;41(10):1024-1027. doi: 10.1097/COC.0000000000000408.
6
Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.癌症护理中可预防和可减轻的不良事件:衡量整个连续过程中的风险和危害。
Cancer. 2017 Dec 1;123(23):4728-4736. doi: 10.1002/cncr.30916. Epub 2017 Aug 17.
7
Risk of other Cancers in Families with Melanoma: Novel Familial Links.黑色素瘤家族中的其他癌症风险:新的家族关联。
Sci Rep. 2017 Feb 15;7:42601. doi: 10.1038/srep42601.
8
Follow-up care of cancer survivors: challenges and solutions.癌症幸存者的随访护理:挑战与对策。
Lancet Oncol. 2017 Jan;18(1):e19-e29. doi: 10.1016/S1470-2045(16)30386-2.
9
Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma.BRAF 抑制剂单独及联合 MEK 抑制剂治疗转移性黑色素瘤的皮肤毒性作用。
JAMA Dermatol. 2015 Oct;151(10):1103-9. doi: 10.1001/jamadermatol.2015.1745.
10
Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review.临床实践指南:识别、筛查和随访原发性皮肤黑色素瘤高危个体:系统综述。
Br J Dermatol. 2015 Jan;172(1):33-47. doi: 10.1111/bjd.13403. Epub 2014 Dec 11.